Researchers are testing an experimental oral drug called PRO-1562 in healthy adults and in adults with relapsing multiple sclerosis who also have long-term vision damage from chronic optic neuropathy. The trial has two parts: a phase 1 safety and absorption study in healthy volun…
Phase 1/2 • Sponsor: Progentos Therapeutics • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC